Keywords: L-DOPA; Pathology; Substantia nigra; Lewy bodies; l-dopa; Levodopa; Dopamine; Genetics; Alpha-synuclein; Rogue protein; Deep brain stimulation;
مقالات ISI L-DOPA (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: L-DOPA; BGTC loop; basal ganglia-thalamocortical loop; CVA; cerebrovascular accident; MRI; magnetic resonance imaging; MSA-P; multiple system atrophy Parkinsonian type; PD; Parkinson's disease; SLD; stuttering-like dysfluency; T2WI; T2-weighted imaging; TBI; tr
Keywords: L-DOPA; 6-OHDA; 6-hydroxydopamine; L-DOPA; L-3,4-dihydroxyphenylalanine; MB; methylene blue; MPP+; 1-methyl-4-phenylpyridinium; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; OD; optical density; p; probenecid; PD; Parkinson's disease; SNpc; substantia nig
Keywords: L-DOPA; MSA-P; L-dopa; Dopamine agonists;
Keywords: L-DOPA; AA; ascorbic acid; ACh; acetylcholine; ADR; adrenaline; ADSV; adsorptive differential pulse stripping voltammetry; AFM; atomic force microscopy; Ala; alanine; Amp; amperometry; ASDPV; anodic stripping differential pulse voltammetry; Asp; aspartate; AuNPs;
Keywords: L-DOPA; Bmax; maximum binding capacity; CNV; choroidal neovascularization; DCT; dopachrome tautomerase; DHI; 5,6-dihydroxyindole; DHICA; 5,6-dihydroxyindole-2-carboxylic acid; DOPA; dihydroxyphenylalanine; HPLC; high performance liquid chromatography; IQ; 5,6-ind
Keywords: L-DOPA; PD; Parkinson's disease; l-dopa; 3-4 dihydroxy-l-phenylalanine; PBLs; peripheral blood lymphocytes; ROS; reactive oxygen species; 8-oxodG; 8-oxo-7,8-dihydro-2â²-deoxyguanosine; MN; micronuclei; TBARS; thiobarbituric acid-reactive substances; PrCAR; prote
Keywords: L-DOPA; Aβ; beta-amyloid; APOE; apolipoprotein E; APP; amyloid precursor protein; AD; Alzheimer's disease; CRISPR; clustered regularly interspaced short palindromic repeats; DAT; dopamine transporter; ER; estrogen receptor; FAD; familial Alzheimer's disease;
Keywords: L-DOPA; Ach; acetylcholine; ADHD; attention-deficit hyperactivity disorder; BDNF; brain-derived neurotrophic factor; BEND; beta-endorphin; BFNA; beta-funaltrexamine; Ca(2+); calcium; CAMK; calmodulin-dependent protein kinase II; cAMP; cyclic adenosine monophospha
Keywords: L-DOPA; ECM; Extracellular Matrix; FBRs; Foreign Body Responses; Dcs; Dendritic Cells; Fg; Fibrinogen; ALB; Albumin; PMNs;; PolyMorphonuclear; FAC; Focal Adhesion Complex; Alumina; (Al2O3), Zirconia (Zro2); THR; Total Hip Replacements; PSZ; Partially Sintered Zir
Keywords: L-DOPA; 3-MT; 3-methoxytyramine; 5-HIAA; 5-hydroxyindoleacetic acid; 5-HT; serotonin (5-hydroxytryptamine); 5-HTP; 5-hydroxy-L-tryptophan; Am; amygdala; Ap; arcopallium; Arch; archistriatum; ATD; acute tryptophan depletion; BBB; blood-brain-barrier; CL; control l
Keywords: L-DOPA; ACTH; adrenocorticotropic hormone; AChR; acetylcholine receptor; ALS; amyotrophic lateral sclerosis; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; Ca2+; a calcium ion; CA1; cornu ammonis area 1, a region in the hippocampus anatomy; CO2; car
Keywords: L-DOPA; 6-OHDA; 6-hydroxydopamine; CA; catecholamine; CaMKII; Ca2+/calmodulin-dependent protein kinase II; CDK; cyclin-dependent kinase; CNS; central nervous system; DA; dopamine; ENS; enteric nervous system; ERK; extracellular signal regulated kinase; GI; gastro
Keywords: L-DOPA; Parkinson; Permethrin; Animal model; Method; Motor disabilities; L-Dopa; Dopamine; Substantia nigra; Behavior; Permethrin (PubChem CID:40326);
Keywords: L-DOPA; α-MSH; α-melanocyte-stimulating hormone; ERK; extracellular signal-regulated kinase; DHICA; 5,6-dihydroxyin-dole-2-carboxylic acid; LC3; light chain 3; L-DOPA; L-3,4-dihydroxyphenylalanine; mTOR; mechanistic target of rapamycin; MITF; microphthalmia-ass
Keywords: L-DOPA; 5-Alpha-Reductase; finasteride; l-DOPA; dyskinesia; Parkinson's disease;
Keywords: L-DOPA; Parkinson; DBS; L-dopa; TMS; EEG;
Keywords: L-DOPA; DA; dopamine; i.c.v; intra-cerebro-ventricular; l-dopa; levodopa; MPTP; 1 méthyl-4-phenyl-1,2,3,6 terahydropyridine; 6-OHDA; 6-hydroxydopamine; PD; Parkinson's disease; SMBS; sodium metabisulfite; SNpc; substantia nigra pars compacta; Parkinson's disease
Keywords: L-DOPA; OA; oxaloacetic acid; l-DOPA; 3,4-dihydroxyphenylalanine; ANS; 1-anilinonaphthalene-8-sulfonate; Tyrosinase; Oxaloacetic acid; Inhibition kinetics;
Structuring colloidal oat and faba bean protein particles via enzymatic modification
Keywords: L-DOPA; BSA; bovine serum albumin; DSC; differential scanning calorimetry; FPI; faba bean protein isolate; L-DOPA; L-3,4-dihydroxyphenylalanine; OPI; oat protein isolate; SC-CO2; supercritical carbon dioxide; SDS-PAGE; sodium dodecyl sulphate polyacrylamide gel e
Analytical methods for quantification of tranexamic acid in biological fluids: A review
Keywords: L-DOPA; ACA; ε-aminocaproic acid; ACN; acetonitrile; BEH; ethylene bridged hybrid; BTB; bromothymol blue; CE; capillary electrophoresis; CPB; cardiopulmonary bypass; CZE; capillary zone electrophoresis; DLLME; dispersive liquid-liquid microextraction; DNS-Cl; da
Keywords: L-DOPA; ANOVA; analysis of variance; DD; constant darkness; EEG; electroencephalography; HD; Huntington's disease; HPA axis; hypothalamic-pituitary-adrenal axis; LD; light-dark; L-DOPA; levodopa; REM sleep; rapid eye movement sleep; SCN; suprachiasmatic nucleus;
Small-molecule models of tyrosinase: From ligand hydroxylation to catalytic monooxygenation of external substrates
Keywords: L-DOPA; BIMZ; bis(1-methylimidazol-2-yl)methane; BPM; 1,1â²-methylenebis-1H-pyrazole; CO; catechol oxidase; CT; charge transfer; dmBPM; 1,1â²-methylenebis(3,5-di-methyl-1H-pyrazole; DFT; density functional theory; l-DOPA; 3,4-dihydroxy-l-phenylalanine; 2,4-DTBP
Keywords: L-DOPA; DA; dopamine; HVA; homovanillic acid; IUGR; intrauterine growth restriction; NA; noradrenaline; DOPAC; 3,4-dihydroxyphenylacetic acid; 5-HT; serotonin; 5-HIAA; 5-hydroxyindoleacetic acid; l-DOPA; l-dihydroxyphenylalanine; TRP; tryptophan; Brain-sparing; C
Keywords: L-DOPA; Dopamine; Ecstasy; Methamphetamine; METH; 3,4-Methylenedioxymethamphetamine; MDMA; Mouse; Neurodegeneration; Neuroinflammation neurotoxicity; Non-human primate; Rat; AC; adenylyl cyclase; AcbSh; nucleus accumbens shell; AcbC; nucleus accumbens core; cAMP;
Keywords: L-DOPA; Melanin; Dispersed pigments; Tyrosinase; Soluble tyrosinase; L-DOPA; Fluoroquinolone; Moxifloxacin; Ciprofloxacin; Tobramycin; BAIT and BADI; FQL; fluoroquinolone; TYR; tyrosinase; TYRM; mushroom tyrosinase; L-DOPA; L-3,4-dihydroxyphenylalanine; AC tap; a
Keywords: L-DOPA; Z-1; caffeic acid-4-2-hydroxy ethyl ester morpholine; Z-2; caffeic acid-4-3-hydroxy propyl ester morpholine; L-DOPA; L-3,4-dihydroxyphenylalanine; L-Tyr; L-tyrosine; DMSO; dimethyl-sulfoxide; EC50; 50% enhancement concentration; Caffeic acid-4-(2-hydroxye
Keywords: L-DOPA; L-dopa; levodopa; DA; dopamine; GCI/R; global cerebral ischemia/reperfusion model modified neurological severity score mNSS; 4-VO; four-vessel occlusion; Levodopa; Cerebral ischemia-reperfusion injury; Learning; Memory; Behavior; Morris water maze;
Keywords: L-DOPA; 5-HT; serotonine; 6-OHDA; 6-hydroxydopamine; AIM; abnormal involuntary movement; CSF; cerebrospinal fluid; DA; dopamine; DBS; deep brain stimulation; EP; enteropedoncular nucleus; GPe; external part of globus pallidus; GPi; internal part of globus pallidu
Keywords: L-DOPA; IKBKAP; inhibitor of kappa light polypeptide gene enhancer in B-cells; IKAP; IKK complex-associated protein; FD; familial dysautonomia; US; United States; CN; cranial nerve; CNS; central nervous system; MRI; magnetic resonance imaging; iPSC; induced pluri
Keywords: L-DOPA; Polyphenols; Antibiotics; Antioxidants; PACAP; Aβ; β-amyloid; AD; Alzheimer's disease; AMPK; AMP-activated protein kinase; BBB; blood-brain barrier; BDNF; brain-derived neurotrophic factor; CAT; catalase; CNS; central nervous system; COX-2; cyclooxyge
Keywords: L-DOPA; BH4; Tetrahydrobiopterin; CSF; Cerebrospinal fluid; HVA; Homovanillic acid; L-Dopa; L-3,4-dihydroxyphenylalanine; PRL; Prolactin; UPDRS; Unified Parkinson's Disease Rating Scale;
Keywords: L-DOPA; Dystonia; Status dystonicus; Baclofen; l-dopa; Children;
Keywords: L-DOPA; Parkinson's disease; Mirror movement; l-Dopa;
Keywords: L-DOPA; Enfermedad de Parkinson; Habla; Voz; Velocidad de elocución; Velocidad articulatoria; L-dopaParkinson's disease; Speech; Voice; Speech rate; Articulation rate; L-dopa
Keywords: L-DOPA; Light colour; Blue LED light; Red LED light; 5-HTP; l-DOPA; Gonad; Japanese quail;
Keywords: L-DOPA; Parkinson's disease; Speech; Voice; Speech rate; Articulation rate; L-DopaEnfermedad de Parkinson; Habla; Voz; Velocidad de elocución; Velocidad articulatoria; L-dopa
Keywords: L-DOPA; NET; neuroendocrine tumors; GI; gastrointestinal track; CgA; chromogranin A; BA; biogenic amines; 5-HT; 5-hydroxytryptamine (serotonin); A; adrenaline; NA; noradrenalin; DA; dopamine; NBL; neuroblastoma; 5-HIAA; 5-hydroxyindoleacetic acid; CAT; catecholam
Keywords: L-DOPA; l-DOPA; l-3,4-dihydroxyphenylalanine; l-Tyr; l-tyrosine; CNSL; cashew nut shell liquid; ANS; 1-anilinonaphthalene-8-sulfonate; Cardanol triene (PubChem CID:11266523); Cardanol diene (PubChem CID:5356113); Cardanol monoene (PubChem CID:5281854); Cardanols;
Keywords: L-DOPA; BZD; benzodiazepine; DAA; dopaminergic agonists; DBS; deep brain stimulation; GSI; general symptomatic index; HAMA; Hamilton anxiety rating scale; ICD; impulse control disorder; IGT; Iowa Gambling Task; l-DOPA; l-3,4-dihydroxyphenylalanine; LEDD; l-DOPA e
Keywords: L-DOPA; DHAP; 2,5-dihydroxy acetophenone; l-DOPA; l-3,4-dihydroxyphenylalanine; DPO; diphenoloxidase; DMF; dimethylformamide; DMSO; dimethylsulfoxide; FA; ferulic acid; 3-(4-HP)PA; 3-(4-hydroxyphenyl)propionic acid; 4-MC; 4-methylcatechol; MCT; medium chain trigl
Keywords: L-DOPA; Angiogenesis; Dyskinesia; Ibuprofen; l-dopa; Parkinsonism; Piroxicam; Rat;
Keywords: L-DOPA; Dopamine; Striatum; Attention; Attentional blink; Parkinson's disease; l-dopa; Consciousness; Cognition;
Keywords: L-DOPA; Striatal microcircuit; Network properties; Parkinsonian circuit; Dyskinetic circuit; l-DOPA;
Keywords: L-DOPA; α-MSH; melanocyte-stimulating hormone; DMSO; dimethylsulfoxide; HEMa; Hightly pigmented adult human epidermal melanocytes; HSP; Hesperetin; L-DOPA; 3,4-dihydroxy-L-phenyalanine; MITF; microphthalmia-associated transcription factor; PBS; phosphate-buffere
Keywords: L-DOPA; Extradiol dioxygenase; l-DOPA; secodopa; Dihydropyrrole; Biosynthesis; Anthramycin; Sibiromycin; Pyrrolo[1,4]benzodiazepine
Keywords: L-DOPA; Pathological gambling; Delay discounting; Parkinson disease; Restless legs syndrome; Impulse control disorder; Dopamine agonist; L-Dopa
Keywords: L-DOPA; Parkinson's disease; Somatosensation; Brain laterality; Touch; l-DOPA
Keywords: L-DOPA; l-DOPA; l-3,4-dihydroxyphenyl-alanine; IR; infrared; Infrared; Inexpensive; Animal; Locomotion; Pharmacology; Equipment;
Keywords: L-DOPA; DA; dopamine; DHA; docosahexaenoic acid; l-DOPA; levodopa; LID; l-DOPA-induced-dyskinesias; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MRM; Multiple reaction monitoring; PD; Parkinson's disease; Pls; Plasmalogen; PlsEtn; Ethanolamine plasmalogens